Boston Scientific‘s Precision Spectra spinal cord stimulator (SCS) system is claimed to provide one and a half times better overall pain relief and two times better low back pain relief than the previous generation Precision Plus SCS system in a recent study.

A part of the company’s PRO observational study, the Lumina cohort study consisted of three patient groups, the first of which included 213 consecutive patients who were treated with the Precision Spectra system for up to 24 months post-implant.

The second group included 130 consecutive patients who were treated with Precision Plus, in a comparative evaluation with the Precision Spectra system, while the third featured 25 patients treated with the system and the new CoverEdge 32 surgical leads for up to six months post-implant.

"Claimed to be the first and only SCS system with Illumina 3D software and 32 contacts, Precision Spectra SCS is capable of providing improved pain relief to patients suffering from chronic pain."

In the Lumina Spectra group, the system lowered overall pain from an average baseline score of 7.17 to 2.98 at 24 months post-implant. Patients with only low back pain in the same group reported a sustained and significant reduction from an average baseline score of 7.21 to 3.2.

The improvement with Spectra was more than twice that of its predecessor for low back pain.

In the Lumina surgical group, the six months post-implant group observed significant reduction in overall pain from an average baseline score of 7.7 to 2.7.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

One of the lead investigators for the study Julie Pilitsis said: "This is strong clinical evidence of the effectiveness of the Precision Spectra system in treating the types of challenging chronic pain patients that physicians see every day."

Claimed to be the first and only SCS system with Illumina 3D software and 32 contacts, Precision Spectra SCS is capable of providing improved pain relief to patients suffering from chronic pain.

Due to the presence of more contacts, the system also provides more coverage of the spinal cord for management of chronic pain.

The Precision Plus SCS system provides a maximum of 16 contacts and two lead ports, with each lead port facilitating the placement of a single lead.